15-min delayed · Aug 25, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering INUV, 3 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $10.00 to $10.00, so the covering firms are broadly aligned. The average target of $10.00 sits 1292% above the current $0.72. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.16 next quarter toward $-0.49 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
As of Aug, 3 of 3 firms rate INUV a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
INUV EPS & revenue forecast
EPS · NEXT QUARTER
$-0.16
Range $-0.19 – $-0.09 · 3 analysts · +292% YoY
Next period, 3 analysts expect INUV to earn $-0.16 a share (range $-0.19 – $-0.09), versus $-0.04 a year earlier. Full-year consensus is $-0.50, growing to $-0.49 the year after.
REVENUE · NEXT QUARTER
$8.4M
Range $8.0M – $8.8M · 3 analysts · -41% YoY
Revenue is expected to reach $8.4M (range $8.0M – $8.8M), -41.3% year-over-year. Full-year consensus is $31.5M, rising to $35.5M next year.
Top analysts covering INUV
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on INUV.
#1
JV
Jack Vander Aarde
Maxim Group · Rank #409
Buy
$12.00+1570.7% to target
Overall win rate
24%
+ Follow
#2
Scott Buck
HC Wainwright & Co. · Rank #413
Buy
$6.00+735.4% to target
Overall win rate
23%
+ Follow
#3
JH
Jon Hickman
Ladenburg Thalmann
Buy
$11.50+1501.1% to target
Coverage
—
+ Follow
#4
RC
Richard Cathcart
HC Wainwright & Co.
Buy
$2.00+178.5% to target
Coverage
—
+ Follow
INUV stock forecast FAQ
What is INUV's average 12-month price target?+
The 1 analysts with a live target average $10.00 for INUV over the next 12 months, ranging from a $10.00 high to a $10.00 low.
Is INUV stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 3 analyst ratings, 3 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
How many Wall Street analysts cover INUV?+
3 analysts have an active rating on INUV, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering INUV?+
Among analysts who currently cover INUV, Jack Vander Aarde of Maxim Group has the strongest overall Quantellect track record (Rank #409). Their current call is Buy with a $12.00 target.
What is INUV's projected EPS for next quarter?+
The consensus estimate is $-0.16 per share (range $-0.19 – $-0.09) across 3 analysts. Full-year EPS is projected at $-0.50, rising to $-0.49 the following year.
How much revenue is INUV expected to report next quarter?+
Consensus revenue is $8.4M (range $8.0M – $8.8M). Full-year revenue is projected at $31.5M, growing to $35.5M next year.
Have analysts been upgrading or downgrading INUV lately?+
As of Aug, 3 of 3 firms rate INUV a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their INUV calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
